Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AstraZeneca Pharma India Ltd. Board/Management Information 2026

Mar 11, 2026

60656_rns_2026-03-11_b716cc85-5cd7-4916-bca0-3c46d3800966.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

==> picture [477 x 66] intentionally omitted <==

March 11, 2026

The Manager- Listing BSE Limited Corporate Relationship Dept., 5[th] Floor, New Trading Ring Rotunda Building, P J Towers, Dalal Street, Fort Mumbai – 400 001

The Manager- Listing National Stock Exchange of India Limited Exchange Plaza, 5[th] Floor, Plot No. C/1, G - Block Bandra –Kurla Complex, Bandra (E) Mumbai – 400 051

Dear Sir / Madam,

Sub: Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) – Regulations, 2015 Appointment of Senior Management Personnel

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’), we hereby inform that based on the recommendation of the Nomination and Remuneration Committee, the Board of Directors of the Company has approved the appointment of Mrs. Sandhya Tejaswini Amanna as Director - Legal, with effect from March 18, 2026.

This being a Senior Management Personnel position in terms of the SEBI Listing Regulations, please find the details as required under the SEBI Circular No. HO/49/14/14(7)2025 - CFD-POD2/I/3762/2026 dated January 30, 2026, attached herewith as Annexure – A .

Kindly take the above information on record.

Thanking you,

For AstraZeneca Pharma India Limited

Digitally signed by TANYA TANYA SANISH SANISH Date: 2026.03.11 16:28:59 +05'30'

Tanya Sanish

Company Secretary & Compliance Officer

==> picture [452 x 59] intentionally omitted <==

==> picture [477 x 66] intentionally omitted <==

Annexure - A

Sl.
No.
Particulars Mrs. Sandhya Tejaswini Amanna
1 Reason for change viz.
appointment~~,~~
~~resignation, removal,~~
~~death or otherwise;~~
Mrs. Sandhya Tejaswini Amanna as Director – Legal
2 Date of appointment~~/~~
~~cessation~~
(as
applicable) and term
ofappointment
Effective March 18, 2026
Term of appointment – Full – time employment
3 Brief Profile Mrs. Sandhya Amanna is a seasoned legal professional with over
two decades of experience across the manufacturing, FMCG, and
pharmaceutical sectors.
She will join the Company from Danone India and brings a broad
and well-rounded legal perspective. Over the course of her career,
she has held multiple leadership responsibilities across legal
advisory, compliance, and governance functions.
As an in-house counsel, she has extensive experience in end-to-end
contract
management, dispute resolution,
and
legal
risk
management. She has also led complex intellectual property
litigation and compliance initiatives within the pharmaceutical
sector.
In her role at Danone India as Head of Legal, Compliance and
Secretarial, she has been responsible for driving the legal,
compliance, and governance agenda for the organization. She works
closely with cross functional leadership teams to manage legal risk,
strengthen compliance frameworks, and support strategic business
decisions.
She holds an LLB degree from University of Mumbai and is an
alumna of Government Law College, Mumbai.
4 Disclosure
of
relationships between
directors
Not Applicable

==> picture [452 x 59] intentionally omitted <==